OTCMKTS:DLHTF Dialogue Health Technologies (DLHTF) Stock Price, News & Analysis → Musk, Bezos, and Gates All On Board… (From Porter & Company) (Ad) Free DLHTF Stock Alerts C$3.79 0.00 (0.00%) (As of 10/5/2023) Add Compare Share Share Today's RangeC$3.79▼C$3.7950-Day RangeC$3.79▼C$3.7952-Week RangeC$2.43▼C$3.79VolumeN/AAverage Volume250 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsStock AnalysisAnalyst Forecasts Get Dialogue Health Technologies alerts: Email Address Ad WealthPressThe Tesla Indicator Is BullishIf you ever thought you’re too late to see significant returns from Tesla stock… Please read this short email. Because a world class trading expert just showed me an entirely new way to target hefty returns inside shares of Tesla. It’s all thanks to one unique trade setup that’s specific to this legendary stock. It’s called the Perfect Tesla Trade. And it couldn’t be more straightforward…>> Click here to join Lance now and he’ll teach you how to execute the Perfect Tesla Trade inside yo About Dialogue Health Technologies Stock (OTCMKTS:DLHTF)Dialogue Health Technologies Inc. operates a digital healthcare and wellness platform in Canada, the United Kingdom, Germany, and Internationally. Its Integrated Health Platform is a healthcare hub that centralizes its programs in a single user-friendly application, which provide access to psychologists, psychotherapists, social workers, physicians, nurses, and health specialists. The company's platform also enables its members and their dependents to access employee assistance program. Dialogue Technologies Inc. was incorporated in 2016 and is headquartered in Montreal, Canada.Read More DLHTF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DLHTF Stock News HeadlinesMay 16, 2023 | msn.comFederal funding must fuel college completion, not just accessMay 12, 2023 | msn.comSecond Android 14 beta will let you know when your app is sending location infoMay 8, 2023 | msn.comAfrica must regulate AI to reap its full benefitsMay 3, 2023 | msn.comGhana must leverage technology for accelerated development—Dr KludjesonMay 2, 2023 | marketwatch.comInsights of Electronic Skin Market with Growing Size by Top key players | MC10, Dialog Devices Limited, Imageryworks PtyApril 21, 2023 | marketwatch.com2023-2030 "Occupational Health Market" Opportunities and Company Growth StrategiesApril 18, 2023 | msn.comAmazon’s New Tool Adjusts Sound So You Can Actually Understand Movie and TV DialogueApril 13, 2023 | finance.yahoo.comCanadians Face Financial Barriers when Prioritizing Well-BeingApril 12, 2023 | marketwatch.comOccupational Health Market 2023 Size and Forecast to 2031March 30, 2023 | msn.comPeople are turning to ChatGPT for "thinspo" advice, a new report has found - and it's seriously worryingMarch 28, 2023 | msn.comDigital Dialogue: How is ChatGPT impacting job seekers?March 24, 2023 | msn.comWGA Proposes Approving AI Written MoviesMarch 24, 2023 | marketwatch.comAutomatic Speech Recognition Market Premium Research Report Forecast 2023 To 2029March 21, 2023 | finance.yahoo.comDialogue Health Technologies Reports Fourth Quarter and Full Year 2022 ResultsMarch 13, 2023 | msn.comTop Umushyikirano resolutions and why they matterFebruary 18, 2023 | marketwatch.comOccupational Health Market is Booming in Near Future 2023-2028February 17, 2023 | nbcnews.comThe U.S. and China are pushing countries to pick sides in their ballooning rivalry — but some are saying noFebruary 16, 2023 | marketwatch.comBluetooth Smart & Smart Ready Market 2023 : Global Industry Share, Key Dynamics and Forecast to 2028February 14, 2023 | msn.comStanislas Dehaene, neuroscientist: ‘Free will is real. No one can predict what you are going to do’February 10, 2023 | msn.comWhy the ChatGPT AI Chatbot Is Blowing Everybody's MindFebruary 10, 2023 | marketwatch.comLow Energy Bluetooth Chipsets Share Likely to Grow At a Impressive CAGRFebruary 9, 2023 | marketwatch.comOccupational Health Market Forecast With Trends, Challenges & Drivers and Key Players Highlights for 2022 to 2029See More Headlines Receive DLHTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dialogue Health Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolOTCMKTS:DLHTF CUSIPN/A CIKN/A Webdialogue.co PhoneN/AFaxN/AEmployees240Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Cherif Habib (Age 41)Co-Founder, CEO & Director Comp: $437.63kMr. Alexis Smirnov (Age 52)Co-Founder & CTO Comp: $319.1kMr. Navaid Mansuri (Age 50)Chief Financial Officer Comp: $351.01kMr. Jean-Nicolas Guillemette (Age 40)Chief Operating Officer Comp: $351.01kJennifer BuckleySr. Vice-Pres of CommercialMr. Jean-Marc AyasDirector of Investor RelationsMelissa AzuelosGen. CounselJean-Christophe de Le RueDirector of Public & Gov. RelationsLilian LauVP of MarketingRandy WetmoreVP of SalesMore ExecutivesKey CompetitorsAclarionNASDAQ:ACONWArcturis DataOTCMKTS:SSYNFAscomOTCMKTS:ACMLFBinovi TechnologiesOTCMKTS:BNVIFBrightSpring Health ServicesNASDAQ:BTSGUView All Competitors DLHTF Stock Analysis - Frequently Asked Questions Should I buy or sell Dialogue Health Technologies stock right now? 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Dialogue Health Technologies in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" DLHTF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DLHTF, but not buy additional shares or sell existing shares. View DLHTF analyst ratings or view top-rated stocks. How have DLHTF shares performed in 2024? Dialogue Health Technologies' stock was trading at C$3.79 on January 1st, 2024. Since then, DLHTF stock has increased by 0.0% and is now trading at C$3.79. View the best growth stocks for 2024 here. How do I buy shares of Dialogue Health Technologies? Shares of DLHTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:DLHTF) was last updated on 5/26/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap Profits$1,500 to $9,400 in one month? (A.I. Trade List)Prosper Trading AcademyElon’s New Device is About to Shock the WorldInvestorPlaceNew Options need New Trading StrategiesNetpicksWrite this ticker symbol down…StocksToTradeElon to Transform U.S. Economy? Porter & CompanyBill Clinton Backing Biden Replacement???The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dialogue Health Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.